Liquidia Corp. (LQDA)
35.86
+4.10
(+12.91%)
USD |
NASDAQ |
Jan 09, 16:00
37.04
+1.18
(+3.29%)
Pre-Market: 09:06
Liquidia Research and Development Expense (Annual): 46.54M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Bruker Corp. | 376.50M |
| Integer Holdings Corp. | 50.44M |
| Armata Pharmaceuticals, Inc. | 34.43M |
| Merck & Co., Inc. | 15.79B |
| AIM ImmunoTech, Inc. | 6.149M |